CCSD code H4000 – Transanal resection of a local rectal growth
H4000 is the CCSD code for transanal resection for local rectal growth. It covers removal of a benign or malignant rectal growth through the anus, with no abdominal incision. Transanal endoscopic microsurgery (TEM) is billed separately as H4122.
The code sits in Chapter 11 of the CCSD Schedule, under Rectum / Anus, and Bupa grades it MAJOR 4. Until March 2025, its descriptor read “Transanal resection for rectal cancer”.
- Group
- 11 Abdomen (excluding urinary and reproductive organs)
- Category
- Rectum / Anus
- Complexity
- MAJOR 4
- Billable
- No
- Code also known as
- transanal local excision for rectal growth, transanal excision of rectal tumor, transanal local resection
Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.
- AI-powered code suggestions
- Real-time compliance checks
- Faster claims, fewer denials
Automate repetitive tasks and focus on what matters most—your patients.
Reduce coding errors and ensure compliance with the latest regulations.
Clean claims, fewer denials, and faster reimbursements.
Powerful insights and reporting to help your practice thrive.
HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide
Key takeaways
CCSD Code H4000 covers transanal resection of a local rectal growth, benign or malignant, removed through the anus with no abdominal incision.
The CCSD Group dropped “rectal cancer” from the descriptor in 2025, so H4000 now covers benign adenomas as well as early cancers.
Transanal endoscopic microsurgery (TEM) has its own code, H4122, even though Bupa grades both codes MAJOR 4.
Missing pre-authorization and an operative note that doesn’t confirm the transanal route are frequent reasons H4000 claims are rejected.
Pabau, the practice management platform we build, keeps the operative note on the same record as the invoice and sends the claim through Healthcode.
What is CCSD Code H4000?
CCSD Code H4000 is the code for transanal resection for local rectal growth. It applies when a colorectal surgeon removes a rectal lesion through the anus, with no abdominal incision. The lesion can be benign, such as a large adenoma, or an early cancer.
The Clinical Coding and Schedule Development (CCSD) Group changed the descriptor in its Procedural Schedule Bulletin, Issue 200. Until March 2025, H4000 read “Transanal resection for rectal cancer”.
Request 7362 replaced it with “Transanal resection for local rectal growth”, with adoption recommended from March 10, 2025.
Bupa’s February 2026 schedule words the code as “Transanal local excision for rectal growth” and grades it MAJOR 4, with a listed fee of £618. The code sits in Chapter 11 of the CCSD Schedule, under Rectum / Anus.
CCSD codes are the billing standard for UK private medical insurance (PMI). Bupa, AXA Health, Aviva, Vitality, WPA and Healix accept them on consultant invoices. NHS trusts code the same operation in OPCS-4 instead.
What transanal resection of a rectal growth involves
The surgeon works inside the rectal lumen, passing instruments through the anus. The growth comes out with a margin of normal tissue, as a mucosal or full-thickness disc of rectal wall. The defect is then closed or left to heal.
The depth of excision follows the lesion. A benign adenoma may need only a submucosal excision. An early cancer usually needs a full-thickness disc, so the pathologist can stage it accurately.
The access platform decides which code applies:
- Conventional transanal excision: retractors and standard instruments passed through the anus, used mainly for low rectal lesions. This is the core use of H4000.
- Transanal endoscopic microsurgery (TEM): a rigid operating rectoscope with insufflation and a magnified view, used for mid and upper rectal lesions. TEM is billed as H4122, “Transanal endoscopic microsurgery”.
- Transanal minimally invasive surgery (TAMIS): a single-port platform with laparoscopic instruments. Bupa’s February 2026 schedule has no TAMIS-specific code, so confirm the insurer’s preferred code before the operation.
- Transanal total mesorectal excision (TaTME): a radical cancer operation that removes the mesorectum. It is billed as H3386, graded CMO 5, and never as a local excision.
H4130, perianal excision of lesion of rectum (including sigmoidoscopy), covers smaller per-anal excisions. Bupa grades it INTER 1 at £245, well below H4000, so the operative note must justify the higher code.
When surgeons choose transanal local excision
Transanal local excision suits rectal growths that can be removed whole without a radical resection. Typical indications include:
- Large benign rectal adenomas that can’t be removed safely by endoscopic polypectomy
- T1 rectal adenocarcinoma with favorable histology: no lymphovascular invasion, no poor differentiation, and clear margins achievable transanally
- Selected T2 cancers in patients unfit for radical surgery, where the multidisciplinary team (MDT) agrees on local excision
- Patients who decline radical resection after full MDT counseling, with informed consent documented
- Lesions within reach of the chosen platform, measured as distance from the anal verge
When the growth is a cancer, staging still follows the TNM 8th edition. UICC’s colorectal-specific TNM 9 update is expected later in 2026. The operative note and pre-operative imaging should support the stage you record. Excision of a T3 lesion without a documented MDT decision is likely to draw an audit query.
For a benign growth, the claim rests on the biopsy result. Add the size or position that ruled out endoscopic removal.
Where H4000 sits in the CCSD rectal code hierarchy
Several CCSD codes bill operations on a rectal growth. They split by access route and by how much tissue comes out. Check the code against the Bupa CCSD code reference before you submit.
Code titles and grades come from Bupa’s CCSD Schedule reference, February 2026 edition. The CCSD Group issues bulletins through the year, so check the current edition before you submit.
Codes commonly confused with H4000
The most common error since 2025 is coding from the old descriptor. Some coders still reserve H4000 for cancer and send a benign adenoma excision elsewhere. Since March 2025, a transanal excision of a benign growth belongs on H4000 too.
TEM is the second trap. A TEM excision is billed as H4122, even though both codes share the MAJOR 4 grade. Name the platform in the operative note, so the code matches the technique.
The third is the abdominal boundary. If the surgeon opens the abdomen or places laparoscopic ports, the operation is no longer H4000. Radical operations such as anterior resection, APR and TaTME carry their own codes. A colon resection does too, so excision of the sigmoid colon is billed as H1000.
The flow below runs those checks in order, starting with the abdominal boundary and then the platform.

What H4000 includes and what is billed separately
H4000 covers the transanal excision itself. That includes tissue handling, hemostasis, and closure or packing of the defect in the same operative episode.
CCSD billing splits the episode between providers. The surgeon, anesthetist and any assistant each invoice the insurer, and H4000 appears only on the surgeon’s claim. These items are billed separately:
- Anesthesia: the anesthetist submits their own CCSD anesthetic code, linked to the surgeon’s claim by the shared authorization number.
- Histopathology: the laboratory bills specimen analysis under its own code. Describe the specimen in the operative note to support that claim.
- Assistant surgeon: an assistant fee needs explicit insurer recognition. The Bupa code search shows assistant eligibility for each procedure.
- Return to theater: bleeding or another complication needs a separate code for the second operation.
- Pre-operative imaging: MRI, endorectal ultrasound and staging CT are billed under diagnostic imaging codes.
Confirm theater and recovery charges with the hospital billing team before you invoice. A recovery fee the hospital already charges is a frequent cause of duplicate-claim flags.
Pro Tip
Check the Healix and Cigna fee schedules for their unbundling rules on colorectal procedures. Both insurers publish guidance on which concurrent codes they accept alongside a primary colorectal code. Submitting histopathology or assistant fees without confirming acceptance is a fast route to a partial denial.
Documentation requirements for H4000 claims
Insurers expect an operative record that proves the transanal route and justifies H4000 over a neighboring code. The operative note should record:
- Confirmation that the approach was entirely transanal, with no abdominal component
- The platform used: conventional instruments or a single-port device (a TEM rectoscope means the claim belongs on H4122)
- Lesion size, distance from the anal verge and clock-face position
- Depth of excision (mucosal, submucosal or full thickness) and margins where measurable
- Specimen orientation for the pathologist
- How the defect was closed or managed
- The pre-operative diagnosis from biopsy, such as adenoma or adenocarcinoma
Supporting documents strengthen the claim. Send the biopsy report and, for a cancer, the MRI or endorectal ultrasound staging and the MDT outcome. For a large adenoma, add the endoscopy report that shows why polypectomy wasn’t suitable.
Digital operative documentation captures each of these fields at the point of care, so the note is complete before the claim goes in.

Pre-authorization: What UK private insurers require
UK private insurers expect pre-authorization before an elective H4000 operation. Treat it as mandatory, because a claim without an authorization reference is usually rejected. The request typically includes:
- The code (H4000) and its current descriptor, “Transanal resection for local rectal growth”
- The indication: biopsy result, lesion size and position, and the stage for a cancer
- The MDT outcome letter where the growth is malignant
- The consultant’s details and insurer recognition number
- Admission details: day case or inpatient, and the proposed theater date
Bupa, AXA Health and Aviva run online pre-authorization portals, while WPA and smaller insurers may take phone or written requests. The Healix fee schedule sets out the clinical evidence it expects for major colorectal procedures.
A request that quotes the old cancer wording for a benign adenoma invites a query. Quote the current descriptor, and carry the reference number onto the invoice.
Pro Tip
Record the insurer authorization reference against each billing party (surgeon, anesthetist and assistant) before any invoice goes out. Mismatched or missing reference numbers on multi-party claims cause processing delays, even when the clinical documentation is complete.
Common reasons H4000 claims are denied
H4000 denials follow a consistent pattern. Check each cause below before you submit.
For an appeal, send the full operative note, the histology and staging documents, and the authorization record. If an emergency prevented pre-authorization, explain why. The Aviva fee schedule guidance describes an appeals process typical of the major UK insurers.
OPCS-4 crosswalk: Mapping H4000 for NHS and mixed billing
Consultants who work in both sectors need both systems. The NHS codes procedures in OPCS-4, while private claims use CCSD.
In OPCS-4, transanal excision of a rectal lesion sits in Chapter H, “Lower Digestive Tract”. The category is H41, “Other operations on rectum through anus”, at codes such as H41.2 and H41.5. The fourth character depends on the technique recorded in the note.
Confirm the exact code in the NHS Classifications Browser. Use the NHS episode code as a guide to the CCSD code, because a one-to-one match isn’t always possible. For the private claim, the CCSD descriptor is the controlling text.
Consultants working across NHS and private sectors should keep the two coding systems separate in their records.
Step-by-step: Submitting an H4000 claim through Healthcode
A clean H4000 claim follows the same sequence from referral to payment. A missed step at any point risks a denial or a delay.
- Confirm cover: check that the patient’s policy covers the operation. Note the policy number, the insurer and any relevant exclusions.
- Get pre-authorization: request H4000 with its current descriptor, the biopsy result and, for a cancer, the MDT letter. Record the reference number.
- Write the operative note promptly: record the route, platform, lesion position, excision depth and specimen handling. Have it ready for the claim pack within 24 hours of discharge.
- Submit with evidence: send the invoice with H4000, the authorization reference, the operative note and the histology. Use the insurer’s preferred channel, such as Healthcode or its own portal.
- Answer queries quickly: insurers may ask for more documents within a set period. Assign a named administrator to watch open queries.
- Appeal with evidence: ask for the denial reason in writing. Reply with the operative note, histology, authorization record and a consultant letter that addresses that reason.
Claims management software that tracks each step keeps claims moving on busy colorectal lists with several insurers. Our guide to UK medical billing software compares the systems that submit through Healthcode.

How Pabau keeps H4000 claims accurate from note to settlement
Paperwork for a transanal excision often ends up in three places. The operative note sits in one system, the invoice in another, and the claim is re-keyed into Healthcode. Each hand-off risks an outdated descriptor or a lost authorization reference.
Pabau’s Healthcode integration turns the invoice you already raise into an electronic claim. The code, amounts and patient details carry over, and Healthcode’s validation rules check the claim before it’s sent.
The operative note, consent forms and biopsy report sit on the same patient record as the invoice. When an insurer queries a claim, your team finds the evidence in one place, and the claims dashboard shows its status until it settles.
Bill colorectal procedures without re-keying claims
Pabau turns the invoice for an H4000 operation into a Healthcode claim and checks it before it’s sent. The operative note stays on the same patient record.

Conclusion
Code H4000 from the descriptor the CCSD Group adopted in March 2025. It covers any local rectal growth excised through the anus, benign or malignant, and a TEM excision goes on H4122.
Before you submit, confirm three facts. The note records a purely transanal route, it names the platform, and the insurer has issued an authorization reference. If one is missing, hold the claim, because a short delay costs less than a rejection and a full resubmission.
To see how Pabau turns colorectal invoices into validated Healthcode claims you can track, book a demo.
Continue your research
Revising a pouch after restorative proctocolectomy? CCSD Code H0480 explains when the abdominal revision code applies.
Frequently asked questions about CCSD Code H4000
What does CCSD code H4000 cover?
CCSD Code H4000 covers transanal resection for local rectal growth. It applies when a surgeon removes a benign or malignant rectal growth through the anus, with no abdominal incision. The code includes the excision, hemostasis and defect management. Anesthesia, histopathology and assistant fees are billed separately.
Is H4000 only for rectal cancer?
No. Until March 2025, the descriptor read “Transanal resection for rectal cancer”. The CCSD Group’s Bulletin Issue 200 (Request 7362) changed it to “Transanal resection for local rectal growth”. The code now covers benign adenomas as well as early cancers.
Is TEM billed as H4000?
No. Transanal endoscopic microsurgery has its own CCSD code, H4122. Bupa grades both H4000 and H4122 as MAJOR 4. Record the platform in the operative note, so the code matches the technique.
How is H4000 different from anterior resection?
H4000 uses only a transanal route, with no abdominal entry and no mesorectal excision. Anterior resection needs open, laparoscopic or robotic abdominal access and has its own codes, such as H3334 for a low anterior resection. Any abdominal component rules out H4000.
What documentation do insurers require for H4000 claims?
Insurers expect an operative note that confirms the transanal route, platform, lesion position, excision depth and margins. Add the biopsy report. For a cancer, also send MRI or endorectal ultrasound staging and the MDT outcome letter. The pre-authorization reference must appear on the invoice.
Can H4000 be billed alongside anesthetic codes?
Yes. The surgeon and anesthetist each submit their own invoice. H4000 goes on the surgeon’s claim, and the anesthetist uses their own CCSD anesthetic code. Both claims share the authorization number and hospital episode.



